SYNPLUG CEMENT RESTRICTOR

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign report with the FDA on 2016-04-21 for SYNPLUG CEMENT RESTRICTOR manufactured by Isotis Orthobiologics, Inc.

Event Text Entries

[43288315] Event could not be confirmed. No radiographs were received. No product will be returned as it remains implanted, no product information was given and no further evaluation of the product can be completed at this time. Patient is asymptomatic. There is no current plan for revision, and the patient will continue to be monitored. Patient activity level is high. Patient's bone quality is unknown. It is unknown if the patient complied with post-operative care instructions. It is unknown if the concomitant device (hip prosthesis) or bone cement contributed to the event. The complaint database was reviewed and indicated there were other related complaints for osteolysis observation. To date, there are no conclusive findings from this or similar complaint investigations, or from technical or clinical information in the literature that proves or disproves a causal relationship between synplug? & optiplug? Biodegradable cement restrictors or the materials they are manufactured with, and periprosthetic osteolysis (or fractures as a result). There are also no data or findings that would suggest that only some subset of all the products manufactured might be affected. The finding of osteolysis surrounding the distal cement restrictor is unexpected, and undesirable; however, periprosthetic osteolysis in total hip arthroplasty is a well-known problem that is typically a multifactorial process and may be identified through routine radiographic follow-up. Device remains in-situ.
Patient Sequence No: 1, Text Type: N, H10


[43288316] Patient came for 10-year-check as planned. Patient had hip transplant right (shaft weber ss, acetabulum firmore 56mm, inlay durasul 36). He is very satisfied with the development. He is without any discomfort on both hips and can do all things he wants to do. Surgeon evaluation: scar without irritation. Fluid walking pattern. Mobility of right hip flexion/extension 120/0/0? , inner rotation/outer rotation 10/0/20? , abduction/ adduction 60/0/45?. Mobility without pain of left hip joint. Small distal osteolysis, distal of shaft of femur. Surgeon's radiological evaluation: regular placement of hip transplant without any sign of loosening or implant failure. Small osteolysis distal of femur shaft. (radiograph was not provided for investigation) patient outcome: the progress is excellent after a total hip prosthesis implantation on the right. Patient is asymptomatic, and currently there is no plan for revision. Surgeon recommend the next check with x-ray in 5 years, i. E. 15 years after hip transplant implantation. Surgeon will continue to monitor.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2090010-2016-00004
MDR Report Key5596202
Report SourceFOREIGN
Date Received2016-04-21
Date of Report2016-04-13
Date of Event2016-03-18
Date Mfgr Received2016-04-13
Date Added to Maude2016-04-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactPETER PERHACH
Manufacturer Street5770 ARMADA DR.
Manufacturer CityCARLSBAD CA 92008
Manufacturer CountryUS
Manufacturer Postal92008
Manufacturer Phone7602165681
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSYNPLUG CEMENT RESTRICTOR
Generic NameCEMENT OBTURATOR
Product CodeLZN
Date Received2016-04-21
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerISOTIS ORTHOBIOLOGICS, INC
Manufacturer AddressIRVINE CA 96218 US 96218


Patients

Patient NumberTreatmentOutcomeDate
10 2016-04-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.